Social costs of illegal drugs, alcohol and tobacco in the European Union: A systematic review
- PMID: 28334460
- DOI: 10.1111/dar.12504
Social costs of illegal drugs, alcohol and tobacco in the European Union: A systematic review
Abstract
Issues: Drug use accounts for one of the main disease groups in Europe, with relevant consequences to society. There is an increasing need to evaluate the economic consequences of drug use in order to develop appropriate policies. Here, we review the social costs of illegal drugs, alcohol and tobacco in the European Union.
Approach: A systematic search of relevant databases was conducted. Grey literature and previous systematic reviews were also searched. Studies reporting on social costs of illegal drugs, alcohol and tobacco were included. Methodology, cost components as well as costs were assessed from individual studies. To compare across studies, final costs were transformed to 2014 Euros.
Key findings: Forty-five studies reported in 43 papers met the inclusion criteria (11 for illegal drugs, 26 for alcohol and 8 for tobacco). While there was a constant inclusion of direct costs related to treatment of substance use and comorbidities, there was a high variability for the rest of cost components. Total costs showed also a great variability. Price per capita for the year 2014 ranged from €0.38 to €78 for illegal drugs, from €26 to €1500 for alcohol and from €10.55 to €391 for tobacco.
Implications and conclusions: Drug use imposes a heavy economic burden to Europe. However, given the high existing heterogeneity in methodologies, and in order to better assess the burden and thus to develop adequate policies, standardised methodological guidance is needed. [Barrio P, Reynolds J, García-Altés A, Gual A, Anderson P. Social costs of illegal drugs, alcohol and tobacco in the European Union: A systematic review. Drug Alcohol Rev 2017;00:000-000].
Keywords: addiction; alcohol; illegal drug; social cost; tobacco.
© 2017 Australasian Professional Society on Alcohol and other Drugs.
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. doi: 10.3310/hta9150. Health Technol Assess. 2005. PMID: 15842952
-
Heated tobacco products for smoking cessation and reducing smoking prevalence.Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013790. doi: 10.1002/14651858.CD013790.pub2. Cochrane Database Syst Rev. 2022. PMID: 34988969 Free PMC article.
Cited by
-
Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment.Br J Radiol. 2019 Sep;92(1101):20180942. doi: 10.1259/bjr.20180942. Epub 2019 May 14. Br J Radiol. 2019. PMID: 30855982 Free PMC article. Review.
-
A mixed method study exploring similarities and differences in general and social services-specific barriers to treatment-seeking among individuals with a problematic use of alcohol, cannabis, or gambling.BMC Health Serv Res. 2024 Aug 22;24(1):970. doi: 10.1186/s12913-024-11304-5. BMC Health Serv Res. 2024. PMID: 39174983 Free PMC article.
-
Identifying available substance use disorder screening tests feasible for use in primary care: A systematic review.Prev Med Rep. 2024 Jan 17;38:102610. doi: 10.1016/j.pmedr.2024.102610. eCollection 2024 Feb. Prev Med Rep. 2024. PMID: 38375183 Free PMC article. Review.
-
Production Losses Associated with Alcohol-Attributable Mortality in the European Union.Int J Environ Res Public Health. 2019 Sep 21;16(19):3536. doi: 10.3390/ijerph16193536. Int J Environ Res Public Health. 2019. PMID: 31546662 Free PMC article.
-
Economic Evaluations of Mindfulness-Based Interventions: a Systematic Review.Mindfulness (N Y). 2022;13(10):2359-2378. doi: 10.1007/s12671-022-01960-1. Epub 2022 Aug 30. Mindfulness (N Y). 2022. PMID: 36061089 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous